Certified by Founder Lodge
Asher Biotherapeutics
United States - South San Francisco , California
START UP
1 Disclosed Funding Rounds $55,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Asher Bio is a biotechnology company developing precisely targeted immunotherapies for cancer and other diseases. Our cis-targeting platform aims to enable selective activation of specific im
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 17 ,2024 | Series C | $55,000,000 |
Wellington Management
Janus Henderson Investors
Third Rock Ventures
Bristol Myers Squibb
Boxer Capital, LLC
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
CREAO AI | $10,000,000 | (Apr 21, 2026)
TraqCheck | $8,000,000 | (Apr 21, 2026)
Antioch | $8,500,000 | (Apr 21, 2026)
ScreenPoint Medical | $14,000,000 | (Apr 21, 2026)
Ultralight | $9,300,000 | (Apr 21, 2026)
